Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.
Last trade$172.52
Day change+$2.82 (+1.66%)
Day range$167.68 – $174.99
Volume128,931
Market cap$1.16B
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$1.16B
Price / earnings
7.07×
Price / book
2.67×
Price / sales
1.46×
EV / sales
1.57×
EV / EBITDA
3.76×
Profitability
Earnings per share
$24.01
Return on assets
15.95%
Return on equity
37.82%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0.77×
Current ratio
4.76×
Quick ratio
4.72×
Cash ratio
1.88×
Cash flow
Price / cash flow
4.5×
Price / free cash flow
4.69×
Free cash flow
$248.1M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for NUTX, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$217.61M
$210.75M
$216.49M
$151.68M
$267.8M
$243.99M
$211.79M
$257.62M
Cost of revenue
$0
$0
$0
$0
$0
$0
$0
$0
Gross profit
$217.61M
$210.75M
$216.49M
$151.68M
$267.8M
$243.99M
$211.79M
$257.62M
Selling, general and administrative
$72.84M
$62.31M
$51.9M
-$53.66M
$63.33M
$127.53M
$72.54M
$43.08M
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$140.52M
$89.03M
$135.22M
$120.76M
$137.44M
$210.31M
$131.13M
$136.25M
Operating income
$77.1M
$121.72M
$81.27M
$30.92M
$130.37M
$33.68M
$80.66M
$121.37M
Interest expense
-$4.86M
-$4.67M
-$4.68M
-$4.98M
-$5.45M
-$5.68M
-$6.12M
-$5.05M
Income before taxes
$72.54M
$117.09M
$76.56M
$25.89M
$123.94M
$23.73M
$71.22M
$108.66M
Income taxes
$15.2M
$20.77M
$13.8M
$9.29M
$27.14M
$7.59M
$20.41M
$9.15M
Net income
$57.34M
$96.32M
$62.76M
$16.61M
$96.8M
$16.14M
$50.81M
$99.51M
Net income attributable to common shareholders
$40.23M
$65.84M
$46.81M
$11.83M
$55.44M
-$17.7M
$21.22M
$61.61M
EBITDA
$82.72M
$127.04M
$86.76M
$36.11M
$135.37M
$38.93M
$85.75M
$119.56M
Basic earnings per share
$5.87
$9.58
$6.70
$1.67
$8.27
-$2.95
$3.74
$11.32
Diluted earnings per share
$5.71
$9.38
$6.52
$1.60
$7.76
-$2.95
$3.33
$8.74
Recent news
Company coverage with links to the original publishers.
Nutex Health (NUTX) reported Q3 2026 revenues declined 18.7% to $217.6M, primarily due to favorable collection-estimate adjustments in the prior year, though hospital visits surged 18.1% to 54,622. The company won over 80% of arbitration determinations and maintained stable revenue per visit near $4,000. With $249.9M in cash, NUTX plans to open two hospitals in Q4 2026 and expand its physician network strategy.
Nutex Health and Elevance Health are recommended as undervalued healthcare stocks despite strong year-to-date performance. Nutex, a small-cap hospital operator, trades at less than 9x trailing earnings with exceptional EPS growth of 2,785% year-over-year. Elevance, a major health insurer, trades at a forward P/E of 14.52 below its five-year average, with consistent dividend increases and strong earnings guidance for 2026-2027.
Five stocks have demonstrated significant price strength and improved earnings estimates following a mixed September market performance. Vince Holding, Vera Bradley, American Outdoor Brands, Nutex Health, and Forum Energy Technologies were identified using screening criteria including positive 4-week price momentum, Zacks Rank #1 ratings, and trading near 52-week highs. All five companies show expected earnings growth exceeding 60% for their current fiscal years.
Four stocks—Nutex Health (NUTX), RCM Technologies (RCMT), Interface (TILE), and Quad/Graphics (QUAD)—were selected based on strong net profit margins, solid EPS growth outlooks, and positive analyst ratings. All four stocks carry Zacks Rank 1 or 2 ratings and VGM Scores of A or B, with recent upward earnings estimate revisions over the past 60 days.
Four companies—Nutex Health (NUTX), RCM Technologies (RCMT), Remitly Global (RELY), and Belden (BDC)—demonstrate strong net profit margins and positive earnings revisions for fiscal 2026. All four stocks carry Zacks Rank ratings of 1 or 2 with VGM Scores of A or B, indicating solid upside potential. Each company has also beaten consensus earnings estimates in their most recent quarters.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.